Clinical Trials Browser

Phase 1/2 × Pancreatic Neoplasms × devimistat × Clear all

NCT03699319 2025-01-23

CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer

Phase 1/2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00907166 2017-03-21

A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients

Phase 1/2 Terminated

Gastrointestinal

Neoplasms, Pancreatic Neoplasms